These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 17146485)
21. Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group. Ng R; Hasan B; Mittmann N; Florescu M; Shepherd FA; Ding K; Butts CA; Cormier Y; Darling G; Goss GD; Inculet R; Seymour L; Winton TL; Evans WK; Leighl NB; ; ; J Clin Oncol; 2007 Jun; 25(16):2256-61. PubMed ID: 17538170 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer. Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice? Tiseo M; Franciosi V; Grossi F; Ardizzoni A Eur J Cancer; 2006 Jan; 42(1):8-16. PubMed ID: 16293409 [TBL] [Abstract][Full Text] [Related]
25. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial. Bennouna J; Senellart H; Hiret S; Vaissiere N; Douillard JY Lung Cancer; 2011 Oct; 74(1):30-4. PubMed ID: 21371774 [TBL] [Abstract][Full Text] [Related]
26. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ; J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710 [TBL] [Abstract][Full Text] [Related]
27. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G; J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834 [TBL] [Abstract][Full Text] [Related]
28. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Alam N; Shepherd FA; Winton T; Graham B; Johnson D; Livingston R; Rigas J; Whitehead M; Ding K; Seymour L Lung Cancer; 2005 Mar; 47(3):385-94. PubMed ID: 15713522 [TBL] [Abstract][Full Text] [Related]
29. The future of adjuvant chemotherapy for resected non-small cell lung cancer. Vansteenkiste JF; Schildermans RH Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951 [TBL] [Abstract][Full Text] [Related]
31. [Adjuvant chemotherapy following radical surgery for non-small cell lung cancer: a randomized study]. Xu G; Rong T; Lin P Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):228-30. PubMed ID: 10921016 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. Pisters KM; Le Chevalier T J Clin Oncol; 2005 May; 23(14):3270-8. PubMed ID: 15886314 [TBL] [Abstract][Full Text] [Related]
33. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group. Goss GD; Logan DM; Newman TE; Evans WK Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724 [TBL] [Abstract][Full Text] [Related]
34. [Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years]. Santo A; Genestreti G; Fiorio E; Terzi A; Lonardoni A; CalabrĂ² F; Campaldini B; Colaluca P; Molino A; Cetto GL Recenti Prog Med; 2006 Apr; 97(4):211-8. PubMed ID: 16729492 [TBL] [Abstract][Full Text] [Related]
35. Early-stage NSCLC: the role of radiotherapy and systemic therapy. Bunn PA J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244 [TBL] [Abstract][Full Text] [Related]
36. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA; Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766 [TBL] [Abstract][Full Text] [Related]
37. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)]. Nakajima E; Katou H Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265 [TBL] [Abstract][Full Text] [Related]